Blog

RSS Feed
Posted by Michael Wonder on 13 Sep 2019

Vertex announces new access agreement with Scottish Government for Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor)

12 September 2019 - Eligible patients in Scotland will immediately have access to Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor) in combination with ...

Read more →
Posted by Michael Wonder on 20 Feb 2018

SMC approves NHS funding for UCB’s Vimpat in children

20 February 2018 - Children living in Scotland with epilepsy will get NHS-funded treatment with UCB’s Vimpat following a green ...

Read more →